Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib

Haematologica. 2017 May;102(5):e207-e209. doi: 10.3324/haematol.2016.163089. Epub 2017 Feb 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow / pathology
  • Carrier Proteins / genetics*
  • Clonal Evolution / drug effects
  • Clonal Evolution / genetics*
  • Disease Progression
  • Gene Frequency*
  • Humans
  • Leukemia, Neutrophilic, Chronic / drug therapy*
  • Leukemia, Neutrophilic, Chronic / genetics*
  • Leukemia, Neutrophilic, Chronic / pathology
  • Leukocyte Count
  • Mutation*
  • Nitriles
  • Nuclear Proteins / genetics*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use*
  • Pyrimidines
  • Receptors, Colony-Stimulating Factor / genetics*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • CSF3R protein, human
  • Carrier Proteins
  • Nitriles
  • Nuclear Proteins
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Receptors, Colony-Stimulating Factor
  • SETBP1 protein, human
  • ruxolitinib